Agela was acquired by Danaher joining the life sciences portfolio which includes Phenomenex, SCIEX, Beckman Coulter Life Sciences, Pall, Leica Microsystems and Molecular Devices. Phenomenex is a leading player in proprietary chromatography consumables, serving the liquid and gas chromatography market, supporting a broad diversity of applications in drug discovery and development, clinical research, forensic toxicology, petrochemical, environmental analysis and food safety. In 2018, Phenomenex and Agela combined as one company to better meet the needs of customer analysis and research requirements.
